维普中文期刊产品整合服务
7篇 您的检索式:作者名="Hedenus M"
    题名 作者 年代 出处 被引量
1Addition of intravenous iron to epotin beta increases hemogloubin response and decreases epoetin dose requirement in anemic patients with lymphopmliferative malignancies: a randomized multicenter study 显示文摘Hedenus M Bigegard G Nasman P 2007Leukemia2007,21,4:1
2Dabepoetin alfa for the treatment of chemotherapy-induced anemia:disease progression and survival analysis from 4 randomized, doable blind placebo-controlled trials显示文摘Hedenus M Vansteenkiste J Kotasek D 2005J Clin Oncol2005,,23:1
3The role of iron supplementation duringepoietin treatment for cancer-related anemia显示文摘Hedenus M Birgegrd G 2009Med Oncol2009,26,1:1
4Darbepoetin alfa for the treatment of chemotherapy-induced anemia:disease progression and survival analysis from four randomized,double-blind,placebo-controlled trials显示文摘Hedenus M Vansteenkiste J Kotasek D 2005J Clin Oncol2005,23,:1
5Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus S 10 g/dL:an exploratory analysis of a phase 3 triaI显示文摘Canon JL Vansteenkiste J Hedenus M 2012Med Oncol2012,29,3:1
6Pharmaeovigi- lance in praetice:erythropoiesis-stimulating agents 显示文摘Hedenus M Ludwig H Henry DH 2014Cancer Med2014,3,5:1
7Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: A randomized, double-blind, placebo-controlled study显示文摘Hedenus M Adriansson M San Miguel J 2003Br J Haematol2003,122,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费